SeekingAlpha · Sep 28, 2026
BlackRock's Discount Management Program May Have Only One Qualifier: BMEZ
BlackRock equity CEFs have been one of the best family of funds to own over the last couple years. Read more on one CEF selection for investors.
NYSE · BMEZ
BlackRock Health Sciences Trust II
Financial Services · Asset Management
$16.38
Up+$0.15 (+0.92%)
Updated Oct 7, 2026, 11:11 PM
SID Score
6.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.54B
- P/E ratio
- 8.62
- Dividend yield
- 11.83%
- 52-week range
- $13.70 – $17.25
- Volume
- 108.4K
- Avg. volume
- 282.63K
Price performance · BMEZ
BMEZ price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
BMEZ closed at $16.38 after 21 trading sessions, down 3.48% for the selected period.
- Last close
- $16.38
- Period change
- -3.48%
- Period low
- $16.03
- Period high
- $16.97
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $16.65 | $16.68 | $16.35 | $16.38 | 108.4K |
| Oct 5, 2026 | $16.51 | $16.6516 | $16.4247 | $16.54 | 134.81K |
| Oct 2, 2026 | $16.62 | $16.75 | $16.445 | $16.47 | 160.69K |
| Oct 1, 2026 | $16.66 | $16.795 | $16.58 | $16.58 | 186.94K |
| Sep 30, 2026 | $16.87 | $17.0401 | $16.70 | $16.70 | 306.95K |
| Sep 29, 2026 | $16.88 | $16.95 | $16.76 | $16.91 | 95.65K |
| Sep 28, 2026 | $16.80 | $16.9395 | $16.70 | $16.83 | 136.74K |
| Sep 25, 2026 | $16.70 | $16.855 | $16.70 | $16.81 | 148.04K |
| Sep 24, 2026 | $16.70 | $16.85 | $16.4527 | $16.80 | 83.89K |
| Sep 23, 2026 | $16.81 | $16.85 | $16.62 | $16.70 | 141.85K |
| Sep 22, 2026 | $16.77 | $16.93 | $16.75 | $16.87 | 84.16K |
| Sep 21, 2026 | $16.61 | $16.75 | $16.5262 | $16.75 | 78.12K |
| Sep 18, 2026 | $16.55 | $16.60 | $16.37 | $16.50 | 144.31K |
| Sep 17, 2026 | $16.52 | $16.63 | $16.45 | $16.55 | 96.51K |
| Sep 16, 2026 | $16.14 | $16.46 | $16.0501 | $16.46 | 101.48K |
| Sep 15, 2026 | $16.14 | $16.2301 | $15.9348 | $16.03 | 228.13K |
| Sep 14, 2026 | $16.52 | $16.69 | $16.17 | $16.27 | 145.82K |
| Sep 11, 2026 | $16.62 | $16.62 | $16.4023 | $16.45 | 173.66K |
| Sep 10, 2026 | $16.64 | $16.7368 | $16.50 | $16.56 | 103.69K |
| Sep 9, 2026 | $16.90 | $16.9799 | $16.594 | $16.75 | 100.46K |
| Sep 8, 2026 | $16.80 | $17.06 | $16.79 | $16.97 | 236.22K |
Latest BMEZ news
The latest Smart Investors Daily articles mentioning BMEZ.
Stock researchCompany · Overview
Company
Market Activity
Research & News
BMEZ research
Overview
Company profile and research snapshot.
Company profile
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Sep 24, 2026
BlackRock Health Sciences Term Trust Q2 2026 Commentary
The performance quoted represents past performance and does not guarantee future results.
SeekingAlpha · Aug 4, 2026
BMEZ: Ride On Multiple Tailwinds Amid Sector Rotation
Explore BlackRock Health Sciences Trust II (BMEZ): a diversified biotech/pharma CEF at a ~10% NAV discount, with covered calls and 2026 tailwindsâread now.
SeekingAlpha · Jun 24, 2026
BlackRock Health Sciences Term Trust Q1 2026 Commentary
Over the quarter, the BlackRock Health Sciences Term Trust increased its exposure to pharmaceuticals and biotechnology firms.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
